Introduction. The aim of the current study was to evaluate the role of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on the prediction of type 2 diabetes in two ethnic populations from Jerba Island, Tunisia. Methods. In this study, we analysed the genotypic and the allelic distributions of the ACE I/D polymorphism and conducted a case/control association study between healthy normoglycaemic controls and diabetic patients in the two studied groups. ACE gene polymorphism was analysed by polymerase chain reaction in 272 individuals consisting of 172 diabetic subjects and 100 controls. Results. The genotype frequencies for DD, ID and II were 75.50%, 19.60% and 4.89% in Arabs and 76.66%, 16.66% and 6.67% in Berbers, respectively, in the case group, and 42.85%, 35.71% and 21.43% in Arabs and 57.50%, 22.50% and 20.00% in Berbers, respectively, in the control group. The DD frequency was significantly higher in the case group than in the control group (p<0.001), suggesting that the DD genotype is associated with an increased susceptibility to type 2 diabetes in our study populations. Conclusions. The current investigation provides new evidence regarding the role of the ACE I/D polymorphism in the pathogenesis of type 2 diabetes in Jerbian populations. Furthermore, it underlines the importance of ethnicity, which should be considered in all studies aiming to test the genetic effects on the susceptibility to type 2 diabetes.
Introduction
Type 2 diabetes mellitus (TD2) is a heterogeneous metabolic disease characterised by insulin resistance in peripheral tissues, together with impaired insulin secretion from pancreatic β-cells. 1 TD2 causes significant morbidity and mortality worldwide; it affects more than 200 million people, and is scheduled to double in a generation. 2 The complexity of TD2 is related to several factors such as genetic heterogeneity, interactions between genes, and the modulating role played by the environment. Despite numerous reports suggesting a substantial genetic contribution to the susceptibility of TD2, no major susceptibility genes have been identified so far. 3 Thus, many common variants in functional and positional candidate genes, including KCNJ11, PPARG, ENPP1, CAPN10 and TCF7L2, have been studied for their possible role as determinants of TD2, with varying levels of agreement between studies. A possible relation between raised serum angiotensin-converting enzyme (ACE) activity and diabetes mellitus has been reported. 4 ACE, a key enzyme in the renin-angiotensin system, catalyses the conversion of angiotensin I to angiotensin II and inactivates bradykinin in many tissues. ACE is a zinc metalloprotease that is widely distributed on the surface of epithelial and endothelial cells. The ACE gene consists of 26 exons and spans 21 kb on the human chromosome 17. The sequence encodes a 1,306-amino acid protein, including a signal peptide. It has a common polymorphism characterised by the insertion (I allele) or deletion (D allele) of a 287-bp Alu repeat sequence in intron 16 that has been suggested to be associated with TD2, 5 coronary heart disease and nephropathy in type 2 diabetic patients. 6 Association studies of ACE I/D polymorphism and type 2 diabetes in various populations have yielded conflicting results. 7 Although the I/D polymorphism is in the intronic region of the ACE gene, many studies have shown that the DD genotype is strongly associated with increased plasma or serum ACE levels. [8] [9] [10] ACE activity in individuals with the DD genotype is twice that found in those with the II genotype.
Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia
This variant has been studied in different ethnic groups, such as African-Americans, Indians and Whites, 11 leading to significantly different conclusions among these groups.
In the Tunisian population, the occurrence of TD2 reaches 9.5% for women and 8.8% for men. 12 The ACE gene has been the subject of investigation in cosmopolitan populations of Tunis in a case/control study leading to a lack of association with TD2. 13 On the other hand, a genetic population approach has been undertaken in the cosmopolitan healthy population of Sfax, indicating an allelic frequency of 0.67 for the D allele. 14 A comparative study has been undertaken on groups of Berbers and Arabs of Jerba Island, leading to ACE gene D variant frequency of 0.61 and 0.77, respectively. 15 Since it has been well established that the Tunisian population is a mosaic of subpopulations, each region, each town or village having its own genetic structure with significant genetic distances between neighbouring populations, 16 case/control studies should involve healthy subjects and patients from the same location (the same town or the same village). Indeed, diversity of genetic structure and way of life may lead to different conclusions even in the same country, particularly for multifactorial diseases such as TD2.
Our interest concerned Jerba Island where different ethnic groups have coexisted for many centuries without intermixing. 17 Many reports have, however, shown a very slight degree of admixture between Jerbian Arabs and Berbers. Taking into account that these groups have the same geographic environment, our aim in the present study was to focus on genetic factors that might influence TD2 occurrence. We hence compared the frequency of ACE I/D polymorphism in the two neighbouring ethnic groups, in a case/control study involving healthy and diabetic subjects.
Research design and methods Subjects
The studied population included 162 unrelated patients with type 2 diabetes and 110 unrelated healthy controls. All subjects originated from Jerba Island and belonged to two ethnic groups: Arabs from Midoun and Houmet Essouk; and Berbers from Guellala and Sedwikch. Phenotypic characteristics of the two analysed groups are shown in table 1. Familial history of diabetes in first degree relatives and lifestyle habits were reported by participants. The study was approved by the local Institutional Ethics Committees and performed in accordance with the Declaration of Helsinki.
Measurements
Weight and height were measured for each subject. Body mass index (BMI, kg/m²) was calculated as weight (kg) divided by height (m) squared.
Diabetic and healthy controls were distinguished based on their glycaemic status, which was defined according to American Diabetes Association criteria 1997:
Normoglycaemia, defined as fasting glucose <6.1 mmol/l without hypoglycaemic treatment; Impaired fasting glucose, defined as fasting plasma glucose between 6.10 and 6.99 mmol/l; Type 2 diabetes, defined as fasting plasma glucose >7.0 mmol/l and/or treatment with antidiabetic agents.
Sample preparation
Venous blood samples were collected in EDTA and plain tubes and were centrifuged at 3,000 rpm to separate plasma and serum. The buffy coat and red blood cell pellet were used for DNA extraction. Leukocyte DNA was extracted by . After an initial denaturation at 94°C for 1 min, the DNA was amplified by 30 PCR cycles of denaturation at 94°C for 1 min, annealing at 58°C for 1 min and extension at 72°C for 2 min, followed by a final extension at 72°C for 5 min. PCR products were separated and sized by electrophoresis on a 6% polyacrylamide gel. The I allele was detected as a 490-bp band, and the D allele was visualised as a 190-bp band. Negative genotypes and some of the positive ones were double genotyped, in order to achieve maximal successful genotyping.
Statistical analysis
The statistical software SPSS version 10.0 (Chicago, USA) was used and the Student Test was used to compare quantitative traits characterising the studied groups. Allelic and genotypic frequencies in diabetic patients and controls were measured using EPI INFO 6 package performing the Student, the Pearson's χ 2 tests and Fisher's exact test (when genotype class was below 5). Odds ratio are given at 95% confidence limits. A p value <0.05 was considered to be statistically significant.
Results
As already noted, the demographic characteristics of the studied population are given in .01) , and the association was only shown under the additive model, indicating that the ACE D allele seems to be less associated with TD2 in Berbers than in Arabs.
Discussion
The ACE gene I/D polymorphism has been implicated as a risk factor for a number of pathologies, such as myocardial infarction, stroke, type 2 diabetes and hypertension, but the relative frequency of this genetic polymorphism in different ethnic groups is unknown. 18 Several previous studies have reported that individuals with the ACE gene DD genotype are more sensitive to insulin. They are more likely to have a lower insulin response to oral glucose loading than individuals with the ID/II genotype in both type 2 diabetic patients and in non-diabetic populations. 19, 20 The relation of this polymorphism with type 2 diabetes has been explored in several studies, but their findings could not be reconciled. [21] [22] [23] [24] The D allele of the ACE gene I/D variant is associated with high ACE activity in Caucasians. Previous studies in non-Caucasian samples have suggested an association between the D allele and type 2 diabetes. In this study, we compared the frequency of the ACE gene I/D polymorphism in two different ethnic groups from Jerba Island, which is an island in southeastern Tunisia. We analysed the genotypic and the allelic distributions of the ACE I/D polymorphism between healthy normoglycaemic controls and diabetic patients. Because population admixture can lead to spurious associations and to avoid the confounding effects due to genetic heterogeneity that characterise the Tunisian population, 25 we restricted our analysis to only well-defined populations in two Berber villages and two Arab villages. Genotype data were available for all subjects, and in each ethnic group, both DD genotype and D allelic frequencies were found to be significantly higher in cases than in control subjects (p<0.01). We suggest that the D allele is associated with TD2 in both ethnic groups. This result is not in agreement with the study published by Arfa et al. 13 on the cosmopolitan population of Tunis, which led to the conclusion that the D allele is not implicated in TD2 risk in the population of Tunis, but gives a risk two-fold in Arab and Berber populations of Jerba. This difference may be due to both genetic and environmental features. In controls, the frequency of the D allele was found to be the same in Tunis as reported by Arfa et al. 13 and in the Arabs of Jerba (61%) and was found to be slightly higher in the Berbers of Jerba (68%). This frequency was found to be higher than that reported for other healthy populations such as Caucasians (54%), 7 Indians (44%), 8 Asians (38%), 9 Pima Indians (29%), 26 and among African-Americans, Native Americans and White Americans (59%, 49% and 44%, respectively). 27 However, the frequencies observed in Tunisia were found to be close to those observed for African-Americans. Hence, we confirm that ethnic differences should be accounted for when studying the ACE gene.
On the other hand, we compared our results in healthy controls to those obtained by other authors on Sfax and Jerbian Berber and Arab groups. 14, 15 The frequency of the D allele was found to be 61% in the Berbers studied by Ennafaa et al. 15 It was found to be higher in Arabs (77%) as compared to Arab Jerbian controls in our sample. This excess observed in Arabs may be due to inclusion in the sample of Ennafaa et al. 15 of subjects that would later develop TD2. There were no differences in the frequencies of the D allele in ACE gene between diabetic Arab and Berber patients (85.29% versus 85.00%), and these frequencies were higher than the frequencies in Caucasian patients. 28 The D allele frequency in Arab and Berber diabetic patients was also higher than that reported in Asian patients. 29 The difference observed in diabetic groups between Arabs and Berbers of Jerba and the cosmopolitan population of Tunis may be attributed to lifestyle that strongly interacts with ACE function. Indeed, some studies on Berber cultural features and nutrition have strongly indicated a lifestyle leading to TD2 which enhances the effect of genetic risk factors. On the other hand, the Arabs of Jerba also have sedentary habits and excessive sugar intake. In light of the robustness of our results and the merits of the case/control design, this may have shown the pressure on the ACE D allele due to different exposure levels to environmental or dietary factors. In fact, the high serum and tissue ACE associated with the D allele would lead to high angiotensin II levels. Renin-angiotensin systems are present in the circulation and in several tissues in which glucose metabolism is controlled, including skeletal muscle, pancreas and adipose tissue.
There is now considerable evidence for angiotensin II promoting the development of TD2 through a number of mechanisms, including interfering with insulin signalling, pro-inflammatory effects on tissue causing endothelial dysfunction, inhibiting adipocyte differentiation and causing β-cell dysfunction via oxidative stress. [30] [31] [32] Non-esterified fatty acids (from triacylglycerol hydrolysis) directly inhibit insulin signalling, 33 and excess intracellular triacylglycerols promote increased oxidative stress and inflammation, which can cause insulin resistance. 34 The properties of angiotensin II affecting insulin signalling and causing oxidative stress would directly influence this.
In conclusion, the current investigation provides new evidence regarding the role of the ACE gene I/D polymorphism in the pathogenesis of type 2 diabetes in Jerbian populations, which may have significant clinical implications. Our results suggest that subjects with the D allele may benefit from earlier therapy with an ACE inhibitor or angiotensin II receptor 1 blocker to reduce ACE activity and subsequently the future risk of TD2 and its associated complications. Furthermore, it underlines the importance of ethnicity, which should be considered in all studies aiming to test the genetic effects on the susceptibility to TD2. 
